0.9987
price up icon8.80%   0.0835
 
loading

Rapt Therapeutics Inc (RAPT) 最新ニュース

pulisher
10:25 AM

There is no way RAPT Therapeutics Inc (RAPT) can keep these numbers up - Sete News

10:25 AM
pulisher
May 01, 2025

A stock that deserves closer examination: RAPT Therapeutics Inc (RAPT) - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Market Recap: RAPT Therapeutics Inc (RAPT)’s Positive Momentum, Closing at 0.93 - DWinneX

May 01, 2025
pulisher
May 01, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Acquired by Geode Capital Management LLC - Defense World

May 01, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 24, 2025

RAPT Therapeutics Inc (RAPT) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 21, 2025

Stock Surge: RAPT Therapeutics Inc (RAPT) Closes at 0.79, Marking a -1.32 Increase/Decrease - DWinneX

Apr 21, 2025
pulisher
Apr 18, 2025

Is RAPT Therapeutics (NASDAQ:RAPT) In A Good Position To Invest In Growth? - Yahoo Finance

Apr 18, 2025
pulisher
Apr 18, 2025

RAPT stock touches 52-week low at $0.78 amid sharp annual decline - Investing.com Canada

Apr 18, 2025
pulisher
Apr 17, 2025

RAPT stock touches 52-week low at $0.78 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 15, 2025

Rapt Therapeutics appoints Jessica Savage as VP, clinical development - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

RAPT Therapeutics (RAPT) Strengthens Leadership with New VP for Clinical Development | RAPT Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

RAPT Therapeutics Deepens Expertise in Allergic Diseases - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

Top Allergy Expert Joins RAPT to Accelerate Novel Food Allergy Treatment Pipeline - Stock Titan

Apr 15, 2025
pulisher
Apr 14, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Recommendation of “Hold” from Brokerages - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

40,218 Shares in RAPT Therapeutics, Inc. (NASDAQ:RAPT) Bought by Sei Investments Co. - Defense World

Apr 13, 2025
pulisher
Mar 20, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Ultragenyx (RARE) Aligns With FDA on Phase III Neuro Study Plans - MSN

Mar 19, 2025
pulisher
Mar 13, 2025

Q1 EPS Forecast for RAPT Therapeutics Increased by Analyst - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Equities Analysts Set Expectations for RAPT FY2026 Earnings - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

RAPT Therapeutics (NASDAQ:RAPT) Given “Buy” Rating at HC Wainwright - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

H.C. Wainwright maintains $10 target on RAPT Therapeutics stock By Investing.com - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

RAPT Therapeutics: Strategic Licensing and Strong Cash Position Support Buy Rating Despite Financial Loss - TipRanks

Mar 10, 2025
pulisher
Mar 07, 2025

RAPT Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

Double Feature: RAPT Therapeutics Takes Center Stage at Major Healthcare Investment Forums - StockTitan

Mar 07, 2025
pulisher
Mar 07, 2025

Promising Developments and Strategic Trials Boost RAPT Therapeutics’ Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

RAPT Therapeutics Focuses on RPT904 Development in 2025 - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

RAPT Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

RAPT THERAPEUTICS Earnings Results: $RAPT Reports Quarterly Earnings - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

RAPT Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

Rapt Therapeutics reports Q4 EPS ($1.14), consensus (36c) - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Can RAPT's $231M War Chest and New Food Allergy Drug Transform Its Future? - StockTitan

Mar 06, 2025
pulisher
Mar 03, 2025

RAPT Therapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView

Mar 03, 2025
pulisher
Feb 27, 2025

RAPT Therapeutics (RAPT) to Release Quarterly Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 23, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Recommendation of “Hold” from Analysts - Defense World

Feb 23, 2025
pulisher
Feb 16, 2025

Still Cautious Over RAPT Therapeutics’ Fresh Start With RPT904 (NASDAQ:RAPT) - Seeking Alpha

Feb 16, 2025
pulisher
Feb 16, 2025

RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 16, 2025
pulisher
Feb 14, 2025

SG Americas Securities LLC Purchases 42,636 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Feb 14, 2025
pulisher
Feb 12, 2025

Leerink Partnrs Has Positive Outlook of RAPT FY2024 Earnings - Armenian Reporter

Feb 12, 2025
pulisher
Feb 11, 2025

FY2024 Earnings Forecast for RAPT Issued By Leerink Partnrs - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

All You Need to Know About Rapt Therapeutics (RAPT) Rating Upgrade to Buy - Yahoo Finance

Feb 10, 2025
pulisher
Feb 08, 2025

RAPT Therapeutics Inc (NASDAQ: RAPT) Up 31.9% From 52-Week Low; YTD Falls -26.58% – Here’s What To Do Now - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 04, 2025

A stock that deserves closer examination: Solidion Technology Inc (STI) - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Analytical Lens: Exploring RAPT Therapeutics Inc (RAPT)’s Financial Story Through Ratios - The Dwinnex

Feb 04, 2025
pulisher
Jan 29, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jan 29, 2025
pulisher
Jan 28, 2025

Form 424B3 RAPT Therapeutics, Inc. - StreetInsider.com

Jan 28, 2025
pulisher
Jan 28, 2025

SEC Form 424B3 filed by RAPT Therapeutics Inc. - Quantisnow

Jan 28, 2025
pulisher
Jan 26, 2025

RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull - MSN

Jan 26, 2025
pulisher
Jan 25, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Stake Boosted by Barclays PLC - Defense World

Jan 25, 2025
pulisher
Jan 14, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

RAPT Therapeutics Plans Phase 2b Trials for RPT904 - TipRanks

Jan 13, 2025
$72.79
price up icon 0.11%
$21.39
price up icon 2.27%
$32.67
price up icon 0.49%
$29.24
price up icon 18.78%
$105.61
price up icon 3.06%
biotechnology ONC
$256.40
price up icon 0.63%
大文字化:     |  ボリューム (24 時間):